A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer

A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer

Background: The current staging system is imprecise for prognostic prediction of early-stage non–small cell lung cancer (NSCLC). This study aimed to develop a robust prognostic signature for early-stage NSCLC, allowing classification of patients with a high risk of poor outcome and specific treatmen...

Full description

Bibliographic Details
Main Authors: Ru He, Shuguang Zuo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
overall survival
risk score
stage
prognostic signature
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00693/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00693/full

Similar Items